Levels of MIR210 in neonatal patient blood in combination with MIR374a, S100B protein, and Neuron-specific enolase (NSE) have shown high accuracy in distinguishing HIE patients from healthy newborns, but also between mild, moderate, and severe HIE (54). This evidence concerns the gene ENO2 and perinatal asphyxia.